WB28182 The effect of lebrikizumab in patients with severe asthma

• Research type

  Research Study

• Full title

  A phase II, randomised, double-blind, placebo-controlled, multicentre trial to assess the oral corticosteroid-sparing effect of lebrikizumab in patients with severe corticosteroid-dependant asthma

• IRAS ID

  102251

• Contact name

  Liam Heaney

• Contact email

  l.heaney@qub.ac.uk

• Sponsor organisation

  F Hoffmann-La Roche Ltd

• Eudract number

  2012-000190-24

• Clinicaltrials.gov Identifier

  NCT01987492

• Research summary

  Permission to publish the Research Summary not granted at this time

• REC name

  HSC REC B

• REC reference

  13/NI/0148

• Date of REC Opinion

  6 Nov 2013

• REC opinion

  Further Information Favourable Opinion